-
BioVie and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals
-
BioVie presents data on bezisterim's biological aging effects
-
BioVie names Amy Chappell and Kameel Farag to board of directors
-
New to The Street Episode #679 Airs Tonight on Fox Business Network
-
New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability
-
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT
-
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST
-
New to The Street Announces Upcoming Bloomberg Air Dates Featuring FLOKI, BioVie Pharmaceuticals, Beeline, Arrive AI, and Commercialville
-
BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
BioVie (BIVI) Unveils Corporate Advisory Board
-
New to The Street Airs on Bloomberg TV Saturday, April 26 at 6:30 PM ET Featuring BioVie (NASDAQ: BIVI), Skip Barber Racing School with CFO Michael Berg, CommercialVille.tv, Sustainable Green Team (OT
-
New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-F
-
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kev
-
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin
-
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevi
-
New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.
-
New to The Street’s FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Bas
-
Brookline Capital Markets Starts BioVie Inc. (BIVI) at Buy
-
New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai (
-
New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai (
-
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With C
-
New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank’s Kevin
-
BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events
-
BioVie Inc. (BIVI) Prices 1.15M Share Offering at $2.83/sh
-
BioVie Inc. (BIVI) Announces Pricing of Registered Direct Offering at $2.83/sh
-
BioVie Inc. (BIVI) Announces Pricing of Registered Direct Offering and Concurrent Private Placement
-
BioVie Inc. (BIVI) Announces Pricing of Registered Direct Offering and Concurrent Private Placement
-
BioVie (BIVI) Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin
-
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
BioVie Inc. (BIVI) Receives Notice of Allowance for United States Patent Application Covering Novel Liquid Formulation of Terlipressin
-
BioVie Inc. (BIVI) Prices 1.96M Share Offering at $1.53/sh
-
BioVie Inc. (BIVI) Announces Proposed Share and Warrant Offering
-
BioVie Inc. (BIVI) Secures All Scientific Approvals Needed to Receive Additional $12.6M of Grant Funding
-
BioVie Inc. (BIVI) Announces FDA Authorization of IND for Phase 2 Trial to Evaluate Bezisterim in Long COVID
-
BioVie Inc. (BIVI) Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process
-
BioVie (BIVI) Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson’s Disease
-
BioVie Inc. (BIVI) Announces 1:10 Reverse Share Split
-
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

